Shanghai Key Laboratory of Compound Chinese Medicines, The Ministry of Education Key Laboratory for Standardization of Chinese Medicines, The State Administration of TCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Central Laboratory, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200021, China.
Neurosci Bull. 2024 Mar;40(3):283-292. doi: 10.1007/s12264-023-01111-z. Epub 2023 Sep 19.
Early growth response protein 1 (Egr-1) triggers the transcription of many genes involved in cell growth, differentiation, synaptic plasticity, and neurogenesis. However, its mechanism in neuronal survival and degeneration is still poorly understood. This study demonstrated that Egr-1 was down-regulated at mRNA and protein levels in the central nervous system (CNS) of experimental autoimmune encephalomyelitis (EAE) mice. Egr-1 knockout exacerbated EAE progression in mice, as shown by increased disease severity and incidence; it also aggravated neuronal apoptosis, which was associated with weakened activation of the BDNF/TGFβ 1/MAPK/Akt signaling pathways in the CNS of EAE mice. Consistently, Egr-1 siRNA promoted apoptosis but mitigated the activation of BDNF/TGFβ 1/MAPK/Akt signaling in SH-SY5Y cells. Our results revealed that Egr-1 is a crucial regulator of neuronal survival in EAE by regulating TGFβ 1-mediated signaling activation, implicating the important role of Egr-1 in the pathogenesis of multiple sclerosis as a potential novel therapy target.
早期生长反应蛋白 1(Egr-1)触发许多参与细胞生长、分化、突触可塑性和神经发生的基因的转录。然而,其在神经元存活和退化中的机制仍知之甚少。本研究表明,实验性自身免疫性脑脊髓炎(EAE)小鼠中枢神经系统(CNS)中 Egr-1 的 mRNA 和蛋白水平下调。Egr-1 基因敲除小鼠的 EAE 进展加重,表现为疾病严重程度和发生率增加;它还加重了神经元凋亡,这与 CNS 中 BDNF/TGFβ 1/MAPK/Akt 信号通路的激活减弱有关EAE 小鼠。一致地,Egr-1 siRNA 促进细胞凋亡,但减轻了 BDNF/TGFβ 1/MAPK/Akt 信号在 SH-SY5Y 细胞中的激活。我们的结果表明,Egr-1 通过调节 TGFβ 1 介导的信号激活,是 EAE 中神经元存活的关键调节剂,提示 Egr-1 在多发性硬化症发病机制中的重要作用,可能成为一种新的治疗靶点。
In Vitro Cell Dev Biol Anim. 2025-5-27
Cancers (Basel). 2022-11-24
Biochim Biophys Acta Rev Cancer. 2022-11